Bradley C. Leibovich

Q: What Schools Are Affiliated With Bradley C. Leibovich

Bradley C. Leibovich is affiliated with the following schools: University of Kentucky, Mayo Clinic College of Medicine and Science, Duke University, University of Cambridge

Bradley C. Leibovich's AcademicInfluence.com Rankings

Philosophy

#6640

World Rank

#9705

Historical Rank

Logic

#3775

World Rank

#4983

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Bradley C. Leibovich's Degrees

Doctorate Medicine University of Minnesota

Why Is Bradley C. Leibovich Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Bradley C. Leibovich's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Renal Mass and Localized Renal Cancer: AUA Guideline (2017) (973)
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. (2006) (843)
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma (2003) (683)
Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. (2008) (672)
Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. (2003) (665)
Every minute counts when the renal hilum is clamped during partial nephrectomy. (2010) (631)
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. (2004) (613)
Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. (2004) (592)
PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma (2007) (530)
The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus (2004) (465)
Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. (2001) (433)
Survival after complete surgical resection of multiple metastases from renal cell carcinoma (2011) (347)
Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. (2015) (345)
Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. (2010) (344)
Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. (2012) (305)
The impact of ischemia time during open nephron sparing surgery on solitary kidneys: a multi-institutional study. (2007) (298)
B7-H4 expression in renal cell carcinoma and tumor vasculature: Associations with cancer progression and survival (2006) (288)
Identification of a Soluble Form of B7-H1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell Carcinoma (2011) (277)
Urachal carcinoma: Clinicopathologic features and long‐term outcomes of an aggressive malignancy (2006) (269)
Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. (2008) (254)
Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness (2005) (253)
T-Cell Coregulatory Molecule Expression in Urothelial Cell Carcinoma: Clinicopathologic Correlations and Association with Survival (2008) (249)
Augmentation of T Cell Levels and Responses Induced by Androgen Deprivation1 (2004) (244)
Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell Carcinoma (2008) (235)
Comparative Effectiveness for Survival and Renal Function of Partial and Radical Nephrectomy for Localized Renal Tumors: A Systematic Review and Meta-Analysis. (2012) (230)
Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. (2009) (221)
Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. (2005) (213)
A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. (2005) (207)
Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. (2012) (194)
Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. (2007) (192)
Tumor-Infiltrating Foxp3−CD4+CD25+ T Cells Predict Poor Survival in Renal Cell Carcinoma (2007) (191)
Sarcomatoid Renal Cell Carcinoma: An Examination of Underlying Histologic Subtype and an Analysis of Associations With Patient Outcome (2004) (185)
Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma (2003) (184)
Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. (2012) (181)
A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. (2004) (179)
Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? (2005) (167)
Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. (2013) (166)
Mayo adhesive probability score: an accurate image-based scoring system to predict adherent perinephric fat in partial nephrectomy. (2014) (163)
618: Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target (2005) (163)
Comparison of warm ischemia versus no ischemia during partial nephrectomy on a solitary kidney. (2010) (160)
Clear Cell Renal Cell Carcinoma: Gene Expression Analyses Identify a Potential Signature for Tumor Aggressiveness (2005) (158)
Percutaneous renal cryoablation: experience treating 115 tumors. (2008) (158)
Complications of contemporary open nephron sparing surgery: a single institution experience. (2005) (155)
Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. (2010) (151)
Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer. (2005) (150)
Predicting the survival of bladder carcinoma patients treated with radical cystectomy (2000) (147)
Costimulatory molecule B7‐H1 in primary and metastatic clear cell renal cell carcinoma (2005) (146)
Survival of patients with carcinoma in situ of the urinary bladder (1999) (145)
TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion. (2003) (139)
A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma. (2003) (132)
Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. (2012) (132)
Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. (2011) (130)
External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma (2008) (129)
The High-Dose Aldesleukin “Select” Trial: A Trial to Prospectively Validate Predictive Models of Response to Treatment in Patients with Metastatic Renal Cell Carcinoma (2014) (127)
Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline. (2019) (125)
Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohort. (2010) (125)
Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma. (2003) (124)
Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines. (2014) (124)
Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy. (2009) (123)
Renal nephrometry score is associated with urine leak after partial nephrectomy (2011) (122)
ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients (2012) (121)
TFE3 Rearrangements in Adult Renal Cell Carcinoma: Clinical and Pathologic Features With Outcome in a Large Series of Consecutively Treated Patients (2012) (121)
Preoperative nomogram predicting 12-year probability of metastatic renal cancer. (2008) (121)
Obesity and survival after radical prostatectomy: A 10‐year prospective cohort study (2006) (117)
Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. (2006) (116)
Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy (2005) (115)
Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved? (2005) (113)
Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a? (2005) (110)
Outcomes following partial nephrectomy by tumor size. (2008) (106)
Small (<4 cm) Renal Mass: Differentiation of Angiomyolipoma without Visible Fat from Renal Cell Carcinoma Utilizing MR Imaging. (2016) (106)
Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity? (2003) (106)
The role of partial nephrectomy for the management of sporadic renal angiomyolipoma. (2007) (105)
Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy (2002) (105)
Survivin and B7-H1 Are Collaborative Predictors of Survival and Represent Potential Therapeutic Targets for Patients with Renal Cell Carcinoma (2007) (104)
Costimulatory B 7-H 1 in renal cell carcinoma patients : Indicator of tumor aggressiveness and potential therapeutic target (2004) (101)
Outcomes Following Complete Surgical Metastasectomy for Patients with Metastatic Renal Cell Carcinoma: A Systematic Review and Meta‐Analysis (2017) (101)
Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. (2019) (99)
High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma (2006) (99)
Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy. (2007) (98)
Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. (2000) (98)
Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy. (2010) (98)
Management of inferior vena cava tumor thrombus in locally advanced renal cell carcinoma (2015) (97)
Perioperative outcomes following surgical resection of renal cell carcinoma with inferior vena cava thrombus extending above the hepatic veins: a contemporary multicenter experience. (2014) (97)
The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy. (2000) (96)
Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery. (2018) (95)
Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer. (2016) (95)
A Novel Grading System for Clear Cell Renal Cell Carcinoma Incorporating Tumor Necrosis (2013) (94)
Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses. (2005) (91)
Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin. (2000) (91)
Percutaneous cryoablation of large renal masses: technical feasibility and short-term outcome. (2007) (90)
Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience. (2007) (90)
Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma. (2011) (90)
Differences in organ system of distant metastasis by renal cell carcinoma subtype. (2008) (89)
Robot‐assisted retroperitoneal lymph node dissection: technique and initial case series of 18 patients (2015) (89)
High sacrectomy for locally recurrent rectal cancer: Can long‐term survival be achieved? (2011) (88)
Predicting disease progression after nephrectomy for localized renal cell carcinoma: The utility of prognostic models and molecular biomarkers (2008) (88)
Development and evaluation of BioScore (2009) (87)
Paraganglioma of the urinary bladder (2000) (87)
Tumor B 7-H 1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up (2006) (87)
Genome-wide association study identifies multiple risk loci for renal cell carcinoma (2017) (86)
Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. (2013) (86)
Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. (2005) (86)
Clinical and pathological features associated with prognosis in patients with papillary renal cell carcinoma. (2012) (85)
Treatment of patients with small renal masses: a survey of the American Urological Association. (2011) (82)
Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage. (2008) (81)
Hemangioma of the urinary bladder (1999) (80)
Ki‐67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other (2007) (79)
Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score. (2007) (79)
Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control. (2015) (77)
Renal Mass Biopsy: Always, Sometimes, or Never? (2016) (76)
The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment. (2018) (76)
Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients. (2017) (75)
A simple method to estimate renal volume from computed tomography. (2013) (73)
The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma (2006) (73)
Neurofibroma of the urinary bladder (1999) (72)
Mononuclear cell infiltration in clear‐cell renal cell carcinoma independently predicts patient survival (2006) (72)
Percutaneous renal cryoablation: local control at mean 26 months of followup. (2010) (72)
A novel prognostic model for patients with sarcomatoid renal cell carcinoma (2015) (72)
The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta‐analysis (2018) (69)
Use of high fidelity operating room simulation to assess and teach communication, teamwork and laparoscopic skills: initial experience. (2009) (69)
Oncologic outcomes following surgical resection of renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter cohort. (2014) (68)
Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review. (2019) (68)
Adenocarcinoma of the prostate: epidemiological trends, screening, diagnosis, and surgical management of localized disease. (2005) (68)
Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival. (2006) (68)
Tumor size predicts the survival of patients with pathologic stage t2 bladder carcinoma (1999) (67)
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma (2016) (66)
Contemporary trends in nephrectomy for renal cell carcinoma in the United States: results from a population based cohort. (2011) (66)
A multidisciplinary evaluation of inter-reviewer agreement of the nephrometry score and the prediction of long-term outcomes. (2011) (65)
Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection. (2017) (65)
Surgical management, complications, and outcome of radical nephrectomy with inferior vena cava tumor thrombectomy facilitated by vascular bypass. (2008) (65)
Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis. (2020) (65)
Small (<2-cm) upper-tract urothelial carcinoma: evaluation with gadolinium-enhanced three-dimensional spoiled gradient-recalled echo MR urography. (2008) (64)
Oncologic Surveillance After Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based Approach. (2015) (64)
Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes (2016) (63)
Development of a multiplexed urine assay for prostate cancer diagnosis. (2008) (63)
Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma. (2007) (63)
Preoperative neutrophil-lymphocyte ratio predicts death among patients with localized clear cell renal carcinoma undergoing nephrectomy. (2014) (61)
Impact of patient age at treatment on outcome following radical retropubic prostatectomy for prostate cancer. (2006) (61)
Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT. (2015) (60)
pT2 classification for renal cell carcinoma. Can its accuracy be improved? (2005) (59)
TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management (2017) (59)
Patients With pT1 Renal Cell Carcinoma Who Die From Disease After Nephrectomy May Have Unrecognized Renal Sinus Fat Invasion (2007) (58)
Chromophobe Renal Cell Carcinoma: The Impact of Tumor Grade on Outcome (2012) (58)
Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients. (2010) (58)
Metastatic potential of a renal mass according to original tumour size at presentation (2012) (57)
Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis. (2017) (57)
Surgical management of renal cell carcinoma. (2006) (57)
Comparative Survival following Initial Cytoreductive Nephrectomy versus Initial Targeted Therapy for Metastatic Renal Cell Carcinoma (2018) (57)
Clinical and radiographic predictors of the need for inferior vena cava resection during nephrectomy for patients with renal cell carcinoma and caval tumour thrombus (2015) (57)
The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses. (2008) (57)
Small (< 4 cm) Renal Masses: Differentiation of Angiomyolipoma Without Visible Fat From Renal Cell Carcinoma Using Unenhanced and Contrast-Enhanced CT. (2015) (56)
B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma. (2005) (56)
Predicting Renal Function Outcomes After Partial and Radical Nephrectomy. (2019) (56)
Extranodal Extension in Lymph Node–Positive Prostate Cancer (2000) (54)
Ascorbic acid–induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma (2019) (54)
Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients. (2005) (54)
Cell proliferation in prostate cancer patients with lymph node metastasis: a marker for progression. (1999) (54)
The adjuvant treatment of kidney cancer: a multidisciplinary outlook (2019) (53)
Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma. (2018) (53)
Squamous papilloma of the urinary tract is unrelated to condyloma acuminata (2000) (52)
Protocol for the examination of specimens from patients with invasive carcinoma of renal tubular origin. (2010) (52)
First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis. (2018) (52)
The influence of obesity-related factors in the etiology of renal cell carcinoma—A mendelian randomization study (2019) (51)
Hormone receptor expression in renal angiomyolipoma: clinicopathologic correlation. (2008) (51)
Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma. (2005) (51)
Long‐term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate‐specific antigen level ≥50 ng/mL (2008) (50)
Percutaneous image-guided adrenal cryoablation: procedural considerations and technical success. (2011) (50)
Multicenter evaluation of an investigational prostate cancer methylation assay. (2009) (49)
The impact of perioperative blood transfusion on survival after nephrectomy for non‐metastatic renal cell carcinoma (RCC) (2014) (48)
p53 Alteration in regional lymph node metastases from prostate carcinoma (1999) (48)
Extranodal extension in regional lymph nodes is associated with outcome in patients with renal cell carcinoma. (2006) (47)
Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness. (2017) (45)
Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long‐term follow‐up (2013) (45)
Renal function outcomes in patients treated with partial nephrectomy versus percutaneous ablation for renal tumors in a solitary kidney. (2011) (45)
Incidence of Succinate Dehydrogenase and Fumarate Hydratase-Deficient Renal Cell Carcinoma Based on Immunohistochemical Screening with SDHA/SDHB and FH/2SC. (2019) (45)
Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence. (2003) (44)
The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma. (2006) (44)
JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management (2019) (44)
Use of the artificial urinary sphincter in men and women (2005) (44)
Histology in mixed germ cell tumors. Is there a favorite pairing? (2004) (43)
History of Urinary Tract Infection and Risk of Renal Cell Carcinoma (2004) (43)
Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi‐Institutional Analysis (2017) (43)
A single-institution experience in image-guided thermal ablation of adrenal gland metastases. (2014) (42)
Potential role of genetic markers in the management of kidney cancer. (2013) (42)
Current staging of renal cell carcinoma. (2003) (40)
Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy. (2016) (40)
After radical retropubic prostatectomy ‘insignificant’ prostate cancer has a risk of progression similar to low‐risk ‘significant’ cancer (2007) (40)
Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of renal cell carcinoma with suprahepatic caval tumor thrombus. (2015) (40)
Association of abnormal preoperative laboratory values with survival after radical nephrectomy for clinically confined clear cell renal cell carcinoma. (2006) (39)
Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality? (2011) (39)
The role of imaging, deliberate practice, structure, and improvisation in approaching surgical perfection (2017) (38)
Renal oncocytoma growth rates before intervention (2012) (37)
Proximity of prostate cancer to the urethra: implications for minimally invasive ablative therapies. (2000) (37)
Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy. (2008) (37)
Lymph Node Dissection is Not Associated with Improved Survival among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity Score Based Analysis (2017) (37)
Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland. (2011) (36)
The rationale and the role of lymph node dissection in renal cell carcinoma (2017) (36)
The relationship of postoperative complications with in‐hospital outcomes and costs after renal surgery for kidney cancer (2013) (36)
Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001 (2006) (35)
Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol (2009) (35)
Outcomes After Cryoablation Versus Partial Nephrectomy for Sporadic Renal Tumors in a Solitary Kidney: A Propensity Score Analysis. (2018) (35)
Contemporary trends in nephrectomy for renal cell carcinoma in the United States: results from a population based cohort (2011) (35)
Practice‐setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeons (2013) (35)
Wide Variation in Opioid Prescribing After Urological Surgery in Tertiary Care Centers (2019) (34)
Complete Surgical Metastasectomy for Renal Cell Carcinoma in the Post-cytokine Era. (2020) (34)
The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass (2018) (32)
The impact of targeted therapy on management of metastatic renal cell carcinoma: trends in systemic therapy and cytoreductive nephrectomy utilization. (2015) (32)
Diabetes mellitus is independently associated with an increased risk of mortality in patients with clear cell renal cell carcinoma. (2014) (32)
Subjective and objective heterogeneity scores for differentiating small renal masses using contrast-enhanced CT (2017) (31)
Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma. (2014) (31)
Urology resident training with an unexpected patient death scenario: experiential learning with high fidelity simulation. (2008) (31)
Detectable prostate specific antigen between 60 and 120 days following radical prostatectomy for prostate cancer: natural history and prognostic significance. (2006) (30)
Prognostic evaluation of perinephric fat, renal sinus fat, and renal vein invasion for patients with pathological stage T3a clear‐cell renal cell carcinoma (2018) (30)
History of urinary tract infection and risk of renal cell carcinoma. (2003) (30)
Three‐dimensional tumour volume and cancer‐specific survival for patients undergoing nephrectomy to treat pT1 clear‐cell renal cell carcinoma (2012) (30)
The impact of histology on clinicopathologic outcomes for patients with renal cell carcinoma and venous tumor thrombus: a matched cohort analysis. (2013) (30)
Percutaneous cryoablation of anterior renal masses: technique, efficacy, and safety. (2010) (30)
Questionable Relevance of γδ T Lymphocytes in Renal Cell Carcinoma1 (2008) (29)
Probe retraction during renal tumor cryoablation: a technique to minimize direct ureteral injury. (2010) (29)
The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER? (2019) (29)
Radiographic size of retroperitoneal lymph nodes predicts pathological nodal involvement for patients with renal cell carcinoma: development of a risk prediction model (2016) (29)
Temporal trends and factors associated with systemic therapy after cytoreductive nephrectomy: an analysis of the National Cancer Database. (2015) (29)
Tumor-Infiltrating Foxp 3 CD 4 + CD 25 + TCells Predict Poor Survival in Renal Cell Carcinoma (2007) (28)
Outcome prediction with p53 immunostaining after radical prostatectomy in patients with locally advanced prostate cancer. (2000) (28)
Impact of Rhabdoid Differentiation on Prognosis for Patients with Grade 4 Renal Cell Carcinoma. (2015) (28)
Predictors of a Successful Urology Resident Using Medical Student Application Materials. (2017) (28)
LBA67 Phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients (Pts) with renal cell carcinoma (RCC) undergoing nephrectomy (PROSPER, ECOG-ACRIN EA8143), a National Clinical Trials Network trial (2022) (28)
Stratification of patient risk based on prostate-specific antigen doubling time after radical retropubic prostatectomy. (2007) (28)
Long‐term outcome of multiple ipsilateral renal tumours found at the time of planned nephron‐sparing surgery (2008) (28)
The association between metformin use and oncologic outcomes among surgically treated diabetic patients with localized renal cell carcinoma. (2015) (27)
Radical retropubic prostatectomy in immunosuppressed transplant recipients. (2008) (27)
Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma (2015) (27)
International consultation on urologic diseases and the European Association of Urology international consultation on locally advanced renal cell carcinoma. (2011) (26)
Clinical and Pathology Findings Associate Consistently with Larger Glomerular Volume. (2018) (26)
Is the GPSM scoring algorithm for patients with prostate cancer valid in the contemporary era? (2007) (26)
Unclassified renal cell carcinoma: impact on survival following nephrectomy. (2010) (26)
Low-Grade Oncocytic Tumor of Kidney (CK7-Positive, CD117-Negative): Incidence in a Single Institutional Experience with Clinicopathological and Molecular Characteristics. (2021) (26)
Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma (2008) (26)
Increasing prostate specific antigen following radical prostatectomy and adjuvant hormonal therapy: doubling time predicts survival. (2006) (25)
How long is too long? The effect of the duration of anaesthesia on the incidence of non‐urological complications after surgery (2008) (25)
Surgical treatment of stage pT3b renal cell carcinoma in solitary kidneys: a case series (2005) (25)
Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes (2017) (25)
Lymph node dissection in the management of renal cell carcinoma. (2008) (25)
Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma (2007) (25)
Analysis of repeat nephron sparing surgery as a treatment option in patients with a solid mass in a renal remnant. (2005) (24)
The effect of benign lower urinary tract symptoms on subsequent prostate cancer testing and diagnosis. (2013) (24)
Long-term outcomes after maximal surgical resection and intraoperative electron radiotherapy for locoregionally recurrent or locoregionally advanced primary renal cell carcinoma. (2012) (24)
Primary surgical therapy for clinical stage T3 adenocarcinoma of the prostate. (1997) (24)
Rare expression of KIT and absence of KIT mutations in high grade renal cell carcinoma. (2006) (23)
BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor (2017) (22)
Second primary malignancies associated with renal cell carcinoma histological subtypes. (2006) (22)
Increased bcl-2 protein levels in prostatic adenocarcinomas are not associated with rearrangements in the 2.8 kb major breakpoint region or with p53 protein accumulation. (1996) (22)
Predictors of Scholarly Productivity, Pursuit of Fellowship, and Academic Practice Among Urology Residents Using Medical Student Application Materials. (2018) (21)
Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy (2016) (21)
Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell renal cell carcinoma. (2008) (20)
Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. (2020) (20)
Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success? (2018) (20)
Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma. (2005) (20)
Reply from Authors re: Christian G. Stief. If a Partial Nephrectomy Could Be Done Safely for a Renal Tumor, Would Radical Nephrectomy Be Considered Malpractice? Eur Urol 2011;60:465–6 (2011) (20)
Are We Using the Best Tumor Size Cut-points for Renal Cell Carcinoma Staging? (2017) (20)
Systematic Review of the Management of Local Kidney Cancer Relapse. (2018) (20)
Differentiation of Benign From Metastatic Adrenal Masses in Patients With Renal Cell Carcinoma on Contrast-Enhanced CT. (2016) (19)
Concomitant surgery for renal neoplasm with pulmonary tumor embolism. (2010) (19)
The Estrogen Pathway: Estrogen Receptor-α, Progesterone Receptor, and Estrogen Receptor-β Expression in Radical Cystectomy Urothelial Cell Carcinoma Specimens. (2015) (19)
Renal Neoplasia in Tuberous Sclerosis: A Study of 41 Patients. (2021) (19)
Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinoma (2012) (17)
Adjuvant external radiation therapy following radical prostatectomy for node-negative prostate cancer (2003) (17)
Surgical treatment of renal cell carcinoma in the immunocompromised transplant patient. (2010) (17)
Exisulind in the treatment of prostate cancer (2005) (17)
Impact of a 3D printed model on patients’ understanding of renal cryoablation: a prospective pilot study (2018) (17)
Comprehensive assessment of renal tumour complexity in a large percutaneous cryoablation cohort (2017) (16)
Urinary collecting system invasion is associated with poor survival in patients with clear‐cell renal cell carcinoma (2017) (16)
The association of statin therapy with clinicopathologic outcomes and survival among patients with localized renal cell carcinoma undergoing nephrectomy. (2015) (16)
Pre-treatment neutrophil-to-lymphocyte ratio predicts tumor pathology in newly diagnosed renal tumors (2016) (16)
Carbonic Anhydrase IX Is an Independent Predictor of Survival in Advanced Renal Clear Cell Carcinoma (2003) (16)
Larger Nephron Size and Nephrosclerosis Predict Progressive CKD and Mortality after Radical Nephrectomy for Tumor and Independent of Kidney Function. (2020) (15)
The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor Thrombus. (2018) (15)
Renal functional outcomes in patients undergoing percutaneous cryoablation or partial nephrectomy for a solitary renal mass (2017) (15)
Questionable relevance of gamma delta T lymphocytes in renal cell carcinoma. (2008) (15)
Complications and Outcomes Associated With Surgical Management of Renal Cell Carcinoma Involving the Liver: A Matched Cohort Study. (2017) (15)
Excellent long-term disease control with modern radiotherapy techniques for stage I testicular seminoma--the Mayo Clinic experience. (2014) (15)
Impact of Parkinson's disease on continence after radical prostatectomy. (2006) (15)
Percutaneous Image-Guided Core Needle Biopsy for Upper Tract Urothelial Carcinoma. (2019) (14)
PROSPER: Phase III RandOmized Study Comparing PERioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143). (2019) (14)
Coffee consumption and risk of renal cell carcinoma (2017) (14)
Surgery for metastatic renal cell cancer (2005) (14)
Three-dimensional Printing for Renal Cancer and Surgical Planning. (2016) (14)
Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma (2016) (14)
Leucine Zipper 4 Autoantibody: A Novel Germ Cell Tumor and Paraneoplastic Biomarker (2021) (13)
Symptomatic Venous Thromboembolism is Associated with Inferior Survival among Patients Undergoing Nephrectomy with Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma (2018) (13)
A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. (2021) (12)
Long Term Outcomes of Patients with Low Grade Cystic Renal Epithelial Neoplasms. (2019) (12)
Case report: percutaneous catheter management of persistent urine leak due to iatrogenic infundibular stenosis after partial nephrectomy. (2009) (12)
Concordance of PD‐1 and PD‐L1 (B7‐H1) in paired primary and metastatic clear cell renal cell carcinoma (2019) (12)
Comparison of prescribing patterns before and after implementation of evidence-based opioid prescribing guidelines for the postoperative urologic surgery patient. (2019) (11)
Patient factors associated with 30-day complications after partial nephrectomy: A contemporary update. (2017) (11)
T-cell co-regulatory molecule expression in renal angiomyolipoma and pulmonary lymphangioleiomyomatosis. (2009) (10)
Evaluation of beta-blockers and survival among hypertensive patients with renal cell carcinoma. (2017) (10)
Prospective evaluation of smartwatch-enabled detection of left ventricular dysfunction (2022) (10)
Pdl-1/pdl-3 (programmed death ligand-1/3) tissue expression and response to treatment with IL2 and antiangiogenic therapies. (2013) (10)
Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinoma. (2013) (10)
Renal Neuroendocrine Neoplasms: A Single-center Experience. (2019) (10)
Iatrogenic splenectomy during nephrectomy for renal tumors (2013) (10)
PREOPERATIVE NOMOGRAM TO PREDICT POSITIVE LYMPH NODES DURING NEPHRECTOMY FOR RENAL CELL CARCINOMA (2008) (10)
Clinicopathologic characteristics and survival for adult renal sarcoma: A population-based study. (2015) (9)
Alcohol consumption, variability in alcohol dehydrogenase genes and risk of renal cell carcinoma (2018) (9)
Metachronous renal tumours after surgical management of oncocytoma (2011) (9)
Synchronous nephron‐sparing approaches for bilateral renal masses: peri‐operative and renal functional outcomes (2018) (9)
Perioperative Morbidity of Lymph Node Dissection for Renal Cell Carcinoma: A Propensity Score-based Analysis. (2017) (9)
Tumor Cell andTumorVasculature Expression of B 7-H 3 Predict Survival in Clear Cell Renal Cell Carcinoma (2008) (9)
A prospective, controlled phase II study of neoadjuvant exisulind therapy before radical prostatectomy: effect on apoptosis. (2012) (9)
Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer (2017) (8)
Renal Neoplasia in Polycystic Kidney Disease: An Assessment of Tuberous Sclerosis Complex–associated Renal Neoplasia and PKD1/TSC2 Contiguous Gene Deletion Syndrome (2021) (8)
Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomy. (2006) (8)
Familial Renal Cell Carcinoma (2013) (8)
Predictors and oncological outcomes following positive surgical margins at partial nephrectomy (2009) (8)
Multimodality Therapy Including Surgical Resection and Intraoperative Electron Radiotherapy for Recurrent or Advanced Primary Carcinoma of the Urinary Bladder or Ureter (2013) (8)
Potential underdetection of pT(3a) renal-cell carcinoma with laparoscopic morcellation. (2007) (8)
Partial versus radical nephrectomy in clinical T2 renal masses (2021) (8)
Safety and Efficacy of Retrograde Pyeloperfusion for Ureteral Protection during Renal Tumor Cryoablation. (2020) (7)
Oncolytic Measles Virotherapy and Opposition to Measles Vaccination. (2019) (7)
Surgical Management and Oncologic Outcomes of Recurrent Venous Tumor Thrombus after Prior Nephrectomy for Renal Cell Carcinoma. (2016) (7)
Assessment of Isochromosome 12p & 12p Abnormalities in Germ Cell Tumors Using FISH, SNP-Arrays & NGS/ Mate-Pair Sequencing. (2021) (7)
Simultaneous versus staged partial nephrectomies for bilateral synchronous solid renal masses. (2020) (7)
1022: Early Complications and Surgical Margin Status Following Radical Retropubic Prostatectomy (RRP) Compared to Robot-Assisted Laparoscopic Prostatectomy (RALP) (2005) (7)
Does left side renal cell carcinoma (RCC) with renal vein/vena cava thrombus predict worse prognosis than equivalent right side RCC tumor thrombus? (2012) (7)
Epididymo-orchitis and testicular abscess due to Nocardia asteroides complex. (2005) (7)
Severity of Preoperative Proteinuria is a Risk Factor for Overall Mortality in Patients Undergoing Nephrectomy (2017) (7)
Outcomes of patients with sarcomatoid renal cell carcinoma: The Mayo Clinic experience. (2013) (7)
Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. (2005) (7)
Association of Partial versus Radical Nephrectomy with Subsequent Hypertension Risk Following Renal Tumor Resection. (2019) (7)
A Higher Foci Density of Interstitial Fibrosis and Tubular Atrophy Predicts Progressive CKD after a Radical Nephrectomy for Tumor (2021) (7)
The impact of histology on survival for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy (2013) (7)
PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients with localized renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN 8143). (2019) (6)
The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomy. (2019) (6)
Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death. (2016) (6)
Concordance of Pathologic Features Between Metastatic Sites and the Primary Tumor in Surgically Resected Metastatic Renal Cell Carcinoma. (2014) (6)
Renal Neoplasia with Papillary Architecture Involving the Pelvicalyceal System. (2020) (6)
Secondary Renal Neoplasia Following Chemotherapy or Radiation in Pediatric Patients. (2020) (6)
Dynamic prediction of metastases after radical prostatectomy for prostate cancer (2011) (6)
Phase II efficacy trial of pazopanib in non-clear cell metastatic renal cell carcinoma (PINCR trial). (2014) (6)
Emulating Target Clinical Trials of Radical Nephrectomy with or without Lymph Node Dissection for Renal Cell Carcinoma. (2020) (6)
Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era. (2018) (6)
A contemporary guide to chromosomal copy number profiling in the diagnosis of renal cell carcinoma. (2021) (6)
The natural history of renal cell carcinoma with isolated lymph node metastases following surgical resection from 2006 to 2013. (2019) (6)
Intratumoral resolution of driver gene mutation heterogeneity in renal cancer using deep learning. (2022) (6)
Predictors of Urology Resident Surgical Skills, Clinical Communication Skills, Common Sense and In-Service Scores (2017) (5)
Lymph node excision for renal cancer. (2013) (5)
1073 RADICAL NEPHRECTOMY FOR BENIGN RENAL MASSES IS ASSOCIATED WITH DIMINISHED OVERALL SURVIVAL COMPARED WITH PARTIAL NEPHRECTOMY (2011) (5)
Assessing the Evidence for the Surgical Management of Renal Cell Carcinoma with Venous Tumor Thrombus: Room to Grow. (2016) (5)
Should Urologists Abandon the Use of Mannitol During Partial Nephrectomy? (2018) (5)
Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma (2018) (5)
Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma. (2012) (5)
641: Is Partial Nephrectomy for Small Renal Masses Associated with Improved Overall Survival Compared with Radical Nephrectomy? (2007) (5)
Histiocytes containing immunoglobulin crystals in the urine of a patient with IgA κ plasmacytoma of the bladder (2004) (5)
Applications of positron emission tomography imaging, intraoperative ultrasonography, magnetic resonance imaging, and angiography in the evaluation of renal masses (2004) (5)
MP69-12 THE ASSOCIATION OF STATIN THERAPY WITH CLINICOPATHOLOGIC OUTCOMES AND SURVIVAL AMONG PATIENTS WITH LOCALIZED RENAL CELL CARCINOMA UNDERGOING NEPHRECTOMY (2015) (5)
Long-term Follow-up of a Matched Cohort Study Evaluating the Role of Adjuvant Radiotherapy for Organ-confined Prostate Cancer With a Positive Surgical Margin. (2017) (4)
Correlation of Online Physician Reviews and Overall Patient Satisfaction. (2018) (4)
Renal hypothermia during partial nephrectomy for patients with renal tumours: a randomised controlled clinical trial protocol (2019) (4)
Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics (2013) (4)
Re: Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. V. Margulis, P. Tamboli, S. F. Matin, M. Meisner, D. A. Swanson and C. G. Wood. J Urol 2007; 178: 1878-1882. (2008) (4)
Percutaneous Cryoablation of Renal Cell Carcinoma with Sinus Vein Involvement Based on Preprocedural Imaging. (2017) (4)
22: Cardiopulmonary Bypass with Circulatory Arrest Versus Veno-Venous Bypass in Patients Undergoing Venous Thrombectomy: Comparison of Mortality and Morbidity (2004) (4)
THE 2017 AMERICAN JOINT COMMITTEE ON CANCER EIGHTH EDITION CANCER STAGING MANUAL: CHANGES IN STAGING GUIDELINES FOR CANCERS OF THE KIDNEY, RENAL PELVIS AND URETER, BLADDER, AND URETHRA: MP86‐17 (2017) (4)
Partial Versus Radical Nephrectomy for the Clinical T1a Renal Mass. (2019) (4)
710: High Expression Levels of Survivin Protein are an Independent Predictor of Poor Outcome Among Patients Treated Surgically for Clear Cell Renal Cell Carcinoma (2006) (4)
Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencing (2019) (4)
Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencing (2021) (4)
Summary from the Kidney Cancer Association's Inaugural Think Thank: Coalition for a Cure. (2020) (4)
EVIDENCE FOR BENEFIT OF ADJUVANT RADIATION THERAPY IN LOCALIZED PROSTATE CANCER WITH POSITIVE SURGICAL MARGIN AT THE PROSTATE BASE (1999) (3)
THE CELL CYCLE INHIBITORS p21WAF1 AND p27KIP1 ARE ASSOCIATED WITH SURVIVAL IN PATIENTS TREATED BY SALVAGE PROSTATECTOMY AFTER IRRIDIATION (1999) (3)
1682 COMPARATIVE EFFECTIVENESS OF PARTIAL AND RADICAL NEPHRECTOMY FOR LOCALIZED RENAL TUMORS ON SURVIVAL AND RENAL FUNCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS (2012) (3)
Patient-Reported Outcomes After Percutaneous Renal Ablation: Initial Experience. (2019) (3)
Letters to the Editor/Errata RE: NEPHRON SPARING SURGERY FOR APPROPRIATELY SELECTED RENAL CELL CARCINOMA BETWEEN 4 AND 7 CM RESULTS IN OUTCOME SIMILAR TO RADICAL NEPHRECTOMY (2004) (3)
Timing and distribution of early renal cell carcinoma recurrences stratified by pathological nodal status in M0 patients at the time of nephrectomy (2020) (3)
Re: Robotic versus Open Level I-II Inferior Vena Cava Thrombectomy: A Matched Group Comparative Analysis: L. Gu, X. Ma, Y. Gao, H. Li, X. Li, L. Chen, B. Wang, Y. Xie, Y. Fan and X. Zhang J Urol 2017;198:1241-1246. (2018) (3)
1784: Association of Paraneoplastic Syndromes with Outcome Following Radical Nephrectomy for Clear Cell Renal Cell Carcinoma (2004) (3)
Intratumoral CD 14 þ Cells and Circulating CD 14 þ HLA-DRlo / neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma (2015) (3)
Imaging , Diagnosis , Prognosis Identification of a Soluble Form of B 7-H 1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell Carcinoma (2011) (3)
MP35-19 THE IMPACT OF EXCESS FAT MASS ON MORTALITY AFTER RADICAL NEPHRECTOMY FOR RENAL CELL CARCINOMA: BEYOND BODY MASS INDEX (2015) (3)
Hospitalization for partial nephrectomy was not associated with intrathecal opioid analgesia: Retrospective analysis (2014) (3)
573 THE RELATIONSHIP OF LYMPH NODE DISSECTION WITH RECURRENCE AND SURVIVAL FOR PATIENTS TREATED WITH NEPHRECTOMY FOR HIGH-RISK RENAL CELL CARCINOMA (2012) (3)
Adjuvant Pazopanib Does Not PROTECT Against Recurrence of High-Risk, Initially Localized Renal Cell Cancer but Does Provide Novel Insights. (2017) (3)
Collecting duct carcinoma: A single-institution retrospective study. (2021) (3)
Use of Personalized Printed 3‐Dimensional Kidney Models for Simulation before Nephron Sparing Surgery: Methodology and Examples from a Case Series (2016) (2)
ONCOLOGICAL OUTCOMES COMPARING INTRAVESICAL AND EXTRAVESICAL BLADDER CUFF EXCISION FOLLOWING RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA: PD66‐11 (2017) (2)
PD59-05 COST EFFECTIVENESS OF ADJUVANT PEMBROLIZUMAB AFTER NEPHRECTOMY FOR RCC: INSIGHTS FOR PATIENT SELECTION FROM A MARKOV MODEL (2022) (2)
The impact of family history on pathological and clinical outcomes in non‐syndromic clear cell renal cell carcinoma (2010) (2)
Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma. (2020) (2)
Outcomes following cytoreductive nephrectomy without immediate postoperative systemic therapy for patients with synchronous metastatic renal cell carcinoma. (2022) (2)
1777: Differences in Site of Distant Metastases by Renal Cell Carcinoma Subtype (2004) (2)
Hypothermia During Partial Nephrectomy for Patients with Renal Tumors: A Randomized Controlled Trial. (2020) (2)
ONCOLOGIC OUTCOMES FOR PATIENTS WITH POSITIVE SURGICAL MARGINS AT PARTIAL NEPHRECTOMY (2008) (2)
Percutaneous resection of metastatic renal cell carcinoma (2019) (2)
MP44-14 PARANEOPLASTIC SYNDROMES ARE ASSOCIATED WITH ADVERSE PROGNOSIS AMONG PATIENTS WITH RENAL CELL CARCINOMA UNDERGOING NEPHRECTOMY (2015) (2)
742: Features Predictive of Local Recurrence Following Nephron-Sparing Surgery for Renal Caell Carcinoma (2006) (2)
Phase II efficacy trial of pazopanib in nonclear cell metastatic renal cell cancer (mRCC): PINCR. (2020) (2)
Re: Samira A. Brooks, A. Rose Brannon, Joel S. Parker, et al. Clear Code34: a prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol 2014;66:77-84. (2014) (2)
Evaluation of soluble B7x as a serum marker in patients with clear cell renal cell carcinoma (2008) (2)
Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients with urothelial carcinoma. (2022) (2)
Kidney cancer: Therapy for metastatic RCC—questions remain (2009) (2)
1801 COMPLICATIONS AND OUTCOMES FOR PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS: RESULTS FROM THE MAYO CLINIC (2012) (2)
T CELL COREGULATORY MOLECULE EXPRESSION IN UROTHELIAL CELL CARCINOMA: A POTENTIAL TARGET FOR THERAPY (2008) (2)
Reply to Aaron M. Potretzke, Jeffrey A. Larson and Sam B. Bhayani's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9. (2015) (2)
Re: Phillip J. Gray, Stacey A. Fedewa, William U. Shipley, et al. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base. Eur Urol 2013;63:823-9. (2013) (2)
Renal Cell Carcinoma with Inferior Vena Cava Extension: Can Classification Be Optimized to Predict Perioperative Outcomes? (2020) (2)
GEMINI: An open-label, single-arm, phase II trial of intraoperative gemcitabine intravesical instillation in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma. (2020) (2)
Reply to Homayoun Zargar, Rafael F. Coelho and Jihad H. Kaouk's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9. (2015) (2)
A comparison of biochemical outcome following salvage prostatectomy or cryosurgery for locally recurrent prostate cancer after radiation therapy (2001) (1)
MP59-20 SURGICAL RESECTION OF ISOLATED RETROPERITONEAL LYMPH NODE RECURRENCE OF RCC: RESULTS FROM A MULTI-INSTITUTIONAL INTERNATIONAL COHORT (2015) (1)
Abstract No. 172: RFA vs. cryoablation: Single center outcomes in the treatment of 500 renal tumors (2010) (1)
Cell Carcinoma Patients with Long-term Follow-up Tumor B 7-H 1 Is Associated with Poor Prognosis in Renal (2006) (1)
Cost-effectiveness of Adjuvant Pembrolizumab After Nephrectomy for High-risk Renal Cell Carcinoma: Insights for Patient Selection From a Markov Model (2022) (1)
Reply to Pascal Mouracade's letter to the editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9. (2015) (1)
MP31-07 SIMULTANEOUS VERSUS STAGED PARTIAL NEPHRECTOMIES FOR BILATERAL SYNCHRONOUS SOLID RENAL MASSES (2019) (1)
Discovery of a novel monoclonal PD-L1 antibody H1A that promotes T-cell mediated tumor killing activity in renal cell carcinoma (2022) (1)
Special Edition EAU-ICUD - Review - Kidney Cancer International Consultation on Urologic Diseases and the European Association of Urology International Consultation on Locally Advanced Renal Cell Carcinoma (2011) (1)
Survival following upfront cytoreductive nephrectomy versus targeted therapy for metastatic renal cell carcinoma. (2018) (1)
1765: An Outcome Prediction Model for Cancer-Specific Survival Following Metastatic Clear Cell Renal Cell Carcinoma (2004) (1)
MP54-19 THE EFFECT OF METFORMIN IN PATIENTS WITH SURGICALLY TREATED RENAL CELL CARCINOMA (2014) (1)
MP25-06 COMPLETE METASTASECTOMY FOR RENAL CELL CARCINOMA IN THE CONTEMPORARY ERA (2019) (1)
Coregulatory Molecule Expression in Urothelial Cell Carcinoma : Clinicopathologic Correlations and Associationwith Survival (2008) (1)
Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling Inhibitors. (2022) (1)
IMMUNOHISTOCHEMICAL BIOMARKERS VERSUS CLINICAL AND PATHOLOGIC FEATURES IN THE PREDICTION OF SURVIVAL FOR PATIENTS WITH METASTATIC RENAL CELL (2009) (1)
A novel clinical decision aid to support personalized treatment selection for patients with CT1 renal cortical masses: Results from a multi-institutional competing risks analysis including performance status and comorbidity. (2020) (1)
Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients undergoing radical cystectomy (RC) for urothelial carcinoma but ineligible for neoadjuvant cisplatin-based chemotherapy. (2020) (1)
SURVIVAL FOLLOWING PARTIAL VERSUS RADICAL NEPHRECTOMY FOR RENAL CORTICAL TUMORS 4-7CM (2009) (1)
Lymph node dissection is not associated with increased 30-day complications among patients undergoing radical nephrectomy for renal cell carcinoma: A propensity-score based analysis (2017) (1)
547 A NATIONAL SURVEY OF RADIATION ONCOLOGISTS AND UROLOGISTS ON ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER (2013) (1)
IDENTIFICATION OF POTENTIAL SERUM MARKERS IN CLEAR CELL RENAL CELL CARCINOMA (2008) (1)
1127: Association of Preoperative Elevated Erythrocyte Sedimentation Rate and Anemia with Survival Following Radical Nephrectomy for Chromophobe, Papillary, and Clear Cell Renal Cell Carcionoma (2006) (1)
Abstract LB-155: Rapid patient derived xenograft avatars that consider tumor heterogeneity for prediction of cancer immunotherapy responses in metastatic renal cell carcinoma patients (2018) (1)
Unplanned Conversion From Partial to Radical Nephrectomy: An Analysis of Incidence, Etiology, and Risk Factors (2022) (1)
LONG TERM OUTCOMES OF PATIENTS WITH CYSTIC CLEAR CELL RENAL CELL CARCINOMA: MP55‐07 (2017) (1)
POD-03.07: High tumor expression of KI-67 is an independent predictor of poor outcome among patients treated surgicaly for clear cell renal cell carcinoma (2007) (1)
Association of topoisomerase II expression and cancer-specific death in patients with surgically resected clear cell renal cell carcinoma. (2013) (1)
Multimodality therapy including surgical resection (SR) and intraoperative electron radiotherapy (IOERT) for locoregionally recurrent (LRR) or advanced primary malignancies of the urinary bladder (UB) or ureter. (2011) (1)
METASTASECTOMY FOR PATIENTS WITH MULTIPLE METASTASES OF RENAL CELL CARCINOMA: A COMPARISON OF COMPLETE VERSE INCOMPLETE RESECTION (2009) (1)
A Diagnostic Approach to Paratesticular Lesions with Tubulopapillary Architecture: A Series of 16 Serous Borderline Tumors/Low-Grade Serous Carcinoma & 14 Well-Differentiated Papillary Mesothelial Tumors and Mesothelioma. (2022) (1)
Nephron-sparing surgery and renal cell carcinoma. (2004) (1)
Cryoablation of cT1 renal masses in the “healthy” patient: Early outcomes from Mayo Clinic. (2017) (1)
Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia (2021) (1)
LONG-TERM FOLLOW-UP OF PATIENTS WITH CARCINOMA IN SITU OF THE URINARY BLADDER (1999) (1)
950: Pre-Operative PSA Doubling Time is More Powerful than PSA or PSA Velocity as a Predictor of Post Radical Prostatectomy Outcomes (2005) (1)
The impact of surgical resection on circulating tumor-reactive cytotoxic T cells for patients with renal tumors. (2020) (1)
Combination of a fillet flap, free tissue transfer, and autologous tissue grafts in pelvic reconstruction following retroperitoneal sarcoma: A case report (2015) (1)
Abstract A62: Alcohol consumption, genetic variation in alcohol dehydrogenase genes, and risk of clear cell renal cell carcinoma (2013) (1)
1403: “Insignificant” Prostate Cancer Treated by Radical Retropubic Prostatectomy has a Risk of Progression Similar to Low-Risk “Significant” Cancer (2007) (1)
Adrenal hematoma after nephrectomy. (2010) (1)
Complications of the incision and patient positioning (2009) (1)
The association of anxiety and depression with mortality risk among patients with clear cell renal cell carcinoma undergoing nephrectomy. (2019) (1)
PD04-01 RENAL CELL CARCINOMA WITH ISOLATED LYMPH NODE INVOLVEMENT: NATURAL HISTORY AND PREDICTORS OF ONCOLOGIC OUTCOMES (2016) (1)
OUTCOMES IN PATIENTS WITH ADVANCED STAGE RENAL CELL CARCINOMA TREATED WITH NEPHRON SPARING SURGERY (2009) (1)
Re: Renal vein or inferior vena caval extension in patients with renal cortical tumors: impact of tumor histology. (2004) (1)
Perioperative Outcomes for Radical Nephrectomy and Level III-IV Inferior Vena Cava Tumor Thrombectomy in Patients with Renal Cell Carcinoma. (2022) (1)
1115: The Impact of Lymphadenectomy at the Time of Nephrectomy for Metastatic RCC (2006) (1)
PD35-07 EVALUATION AND MANAGEMENT OF RENAL FOSSA RECURRENCE FOLLOWING NEPHRECTOMY FOR RENAL CELL CARCINOMA (2015) (1)
963: Histologic Coagulative Tumor Necrosis: An Important Prognostic Feature of Renal Cell Cancer (2005) (1)
MP35-02 PRETREATMENT NEUTROPHIL-TO-LYMPHOCYTE RATIO CAN PREDICT TUMOR AGGRESSIVENESS IN NEWLY DIAGNOSED RENAL LESIONS (2015) (1)
1268: Accuracy of Predicting Eventual PSA Doubling Time Using Early Detectable PSA Results (2004) (1)
Validation of an inverse association between programmed death ligand 1 (PDL1) and genes in the vascular endothelial growth factor (VEGF) pathway in primary clear cell renal cell (ccRCC). (2013) (1)
1423: The Impact of Gleason Score on the Predictive Value of PSA Doubling Time (2007) (1)
SURGICAL RESECTION OF ISOLATED RETROPERITONEAL LYMPH NODE RECURRENCE OF RENAL CELL CARCINOMA (2008) (1)
Observations on transatlantic renal cell cancer surgery outcomes (2016) (1)
Frequency and Predictors of Renal Transplantation Among Patients Rendered Surgically Anephric for Sporadic Renal Cancer. (2019) (1)
746: Mononuclear Cell Infiltration in Clear Cell Renal Cell Carcinoma Independently Predicts Patient Survival (2006) (1)
Comment on: Radical Nephrectomy for pT1a Renal Masses May be Associated With Decreased Overall Survival Compared With Partial Nephrectomy. Authors' reply (2008) (1)
Comment on: Renal vein or inferior vena caval extension in patients with renal cortical tumors: Impact of tumor histology. Authors' reply (2004) (0)
961: Scoring Algorithm to Predict Cancer-Specific Survival for Patients with Metastatic Renal Cell Carcinoma (2005) (0)
CHARACTERIZATION OF ONCOLYTIC MEASLES VIRUS IN PATIENT‐DERIVED RENAL CELL CARCINOMA XENOGRAFTS GROWN ON CHICKEN CHORIOALLANTOIC MEMBRANES AS A MODEL FOR EARLY METASTATIC DISEASE: MP72‐15 (2018) (0)
Carbonic Anhydrase IX Expression in Clear Cell Renal Cell Carcinoma and Normal Tissues : Experiences From (Radio) Immunotherapy. Authors' reply (2008) (0)
957 The impact of non-clear cell histology on outcome for patients with renal cell carcinoma and venous tumor thrombus (2013) (0)
1090 EVALUATION OF MODIFIABLE AND NON-MODIFIABLE FEATURES ASSOCIATED WITH RENAL FUNCTION FOLLOWING PARTIAL NEPHRECTOMY (2011) (0)
1252 THREE DIMENSIONAL TUMOR VOLUME AND CANCER-SPECIFIC SURVIVAL FOR PATIENTS UNDERGOING NEPHRECTOMY TO TREAT PT1 CLEAR CELL RENAL CELL CARCINOMA (2011) (0)
T1940 Resection of Hepatic Metastases from Germ Cell Tumor: Is It Worth It? (2008) (0)
Reply by Authors. (2019) (0)
830: PSA Doubling Time is an Important Predictor of Outcome in Patients with Hormone Refractory Recurrence following Prostatectomy (2005) (0)
Effect of routine ipsilateral adrenalectomy on cancer-specific survival and risk of adrenal insufficiency for patients with pT3/4 renal cell carcinoma. (2011) (0)
Therapeutic Counseling for the Medical Management of Renal Cell Carcinoma (2008) (0)
Inferior vena cava tumour thrombus and renal cell carcinoma (2018) (0)
MP72-12 ARTIFICIAL INTELLIGENCE ANALYSIS OF PRE-OPERATIVE ECGS CAN PREDICT POST-OPERATIVE DEATH AND MAJOR CARDIAC COMPLICATIONS (2023) (0)
MP70-15 INCREASING COMPLEXITY OF TUMOR THROMBI IN RENAL CELL CARCINOMA OVER 40 YEARS OF EXPERIENCE (2015) (0)
Association and prognostic impact of peripheral blood counts with tumor programmed death ligand one expression. (2015) (0)
MP64-19 FACTORS PREDICTING BLOOD LOSS AND POSITIVE MARGINS AT TIME OF PARTIAL NEPHRECTOMY: ANALYSIS OF A CONTEMPORARY COHORT (2016) (0)
PD35-11 PREOPERATIVE MULTIVARIABLE PROGNOSTIC MODELS FOR PREDICTION OF SURVIVAL AND MAJOR COMPLICATIONS FOLLOWING SURGICAL RESECTION OF RENAL CELL CARCINOMA WITH SUPRAHEPATIC CAVAL TUMOR THROMBUS (2015) (0)
Abstract 10: Concordance of BAP1, PBRM1, Ki-67, and TOPOIIa protein expression in primary clear cell renal cell carcinoma tumors and patient-matched metastatic tumors (2016) (0)
Exploring the association between renal cell carcinoma (RCC) and myeloid malignancies. (2017) (0)
718: Influence of Activated T Cells on Bladder Cancer Progression (2004) (0)
RENAL FUNCTIONAL OUTCOMES IN PATIENTS UNDERGOING PARTIAL NEPHRECTOMY OR PERCUTANEOUS CRYOABLATION FOR A SOLITARY RENAL MASS: MP59‐14 (2017) (0)
MP78-02 URINARY COLLECTING SYSTEM INVASION IS ASSOCIATED WITH POOR SURVIVAL IN CLEAR CELL RENAL CELL CARCINOMA PATIENTS (2016) (0)
399: Complete Tumor Regression of Established Murine Renal Cell Carcinoma Following CD4+ T Cell Depletion and B7-H1 Blockade (2006) (0)
724 Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma (2015) (0)
MP04-19 IMPACT OF SURGERY ON CYTOTOXIC ACTIVITY OF PATIENT-DRIVEN CD8 T CELL (2023) (0)
1108: Surgical Management, Complications, and Outcome of Vascular Bypass for Renal Cell Carcinoma with Venous Tumor Thrombus (2007) (0)
MP-19.15: Urinary fluorescence in situ hybridization predicts long-term disease status after bacillus Calmette-Guerin therapy (2007) (0)
Survival outcomes for patients with surgically induced end-stage renal disease. (2019) (0)
Urological Oncology: Adrenal, Renal, Ureteral and Retroperitoneal Tumors (2014) (0)
MP10-15 ANALYSIS OF PRESCRIBING PATTERNS AFTER IMPLEMENTATION OF EVIDENCE-BASED OPIOID PRESCRIBING GUIDELINES FOR THE POSTOPERATIVE UROLOGIC SURGERY PATIENT (2019) (0)
Risk of bladder cancer following external beam radiation for prostate cancer (2004) (0)
POD-01.09: A validation/evaluation of 5 postoperative prostate cancer prognostic tools (2007) (0)
Cardiopulmonary bypass with circulatory arrest versus veno-venous bypass in patients undergoing venous thrombectomy Comparison of mortality and morbidity (2004) (0)
PD46-12 LONG TERM OUTCOMES OF PATIENTS WITH LOW GRADE CYSTIC EPITHELIAL RENAL NEOPLASMS (2019) (0)
PD02-07 A NOVEL CLINICAL DECISION AID TO SUPPORT PERSONALIZED TREATMENT SELECTION FOR PATIENTS WITH RENAL CORTICAL MASSES ≤7 CM: RESULTS FROM A MULTI-INSTITUTIONAL COMPETING RISKS ANALYSIS INCLUDING PERFORMANCE STATUS AND COMORBIDITY (2020) (0)
MP50-15 CHROMOPHOBE RENAL CELL CARCINOMA – EVIDENCE FOR A NEW GRADING SYSTEM (2020) (0)
Partial nephrectomy in the treatment of renal tumors with concomitant venous tumor thrombosis (VTT) of renal vein branches: Retrospective, multi-center analysis of perioperative, functional, and oncologic outcomes (2017) (0)
Evaluation of post-operative complications and prolonged length of stay following cytoreductive nephrectomy. (2015) (0)
1652: Independent Validation of the 2003 AJCC Tumor Staging System Using a Large Single-Institution Cohort of Patients Treated with Radical Nephrectomy (2004) (0)
422 Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients with urothelial carcinoma (2021) (0)
1110: Cystic Clear Cell Renal Cell Carcinoma is Cured by Surgical Resection (2006) (0)
PD08-04 VIRTUAL RENAL MASS BIOPSY: PREDICTING RENAL TUMOR HISTOLOGY ON ABDOMINAL CT IMAGES USING MACHINE LEARNING (2023) (0)
1150: Impact of the PSA Era on Pathological and Clinical Outcomes after Radical Prostatectomy in Gleason 8-10 Cancers (2007) (0)
PD24-03 SURVIVAL FOLLOWING UPFRONT CYTOREDUCTIVE NEPHRECTOMY VERSUS TARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMA (2018) (0)
Should there be a size limit for elective nephron-sparing surgery? (2003) (0)
MP47-03 MAYO CLINIC VALIDATION OF THE AMERICAN UROLOGIC ASSOCIATION RISK GROUPS FOR LOCALIZED RENAL CANCER (2022) (0)
POS-02.88: Gamma-delta T lymphocytes are of no prognostic value in clear cell renal cell carcinoma (2007) (0)
1779: Cancer-Specific Survival in Patients with PT2 Renal Cell Carcinoma: is the Current Tumor Classification Accurate? (2004) (0)
Deferred cytoreductive nephrectomy in the management of metastatic renal cell carcinoma: A systematic review and meta-analysis (2022) (0)
Survival outcomes of metastasis-directed therapy for solitary sites of metastatic clear cell renal cell carcinoma. (2023) (0)
MP66-03 DISTRIBUTION OF M0 RENAL CELL CARCINOMA METASTASES STRATIFIED BY PATHOLOGIC NODAL STATUS (2018) (0)
Perioperative outcomes following surgical resection of renal cell carcinoma with upper level IVC thrombus: A contemporary multicenter experience. (2014) (0)
PARTIAL NEPHRECTOMY VERSUS CRYOABLATION FOR TUMORS IN SOLITARY KIDNEYS: A PROPENSITY SCORE ANALYSIS: MP100‐17 (2017) (0)
65 SURGICAL VOLUME PREDICTS THE LIKELIHOOD OF OFFERING ELECTIVE PARTIAL NEPHRECTOMY AMONG KIDNEY SURGEONS IN THE AMERICAN UROLOGIC ASSOCIATION (2011) (0)
MP28-12 THE IMPACT OF METASTASIS HISTOPATHOLOGY ON SURVIVAL FOR PATIENTS WITH ADVANCED RENAL CELL CARCINOMA (2023) (0)
Effect of Dataset Size and Medical Image Modality on Convolutional Neural Network Model Performance for Automated Segmentation: A CT and MR Renal Tumor Imaging Study. (2023) (0)
1604: Cancer-Specific Mortality is Increased by Erythrocyte Transfusion in Patients Undergoing Radical Retropubic Prostatectomy (2006) (0)
Aberrant expression of costimulatory B7-H1 in clear cell renal cell carcinoma (2005) (0)
CRYOABLATION OF CT1 RENAL MASSES IN “HEALTHIER” PATIENTS: EARLY OUTCOMES FROM MAYO CLINIC: MP100‐06 (2017) (0)
1250: Pre-Surgical Nomogram Predicting 12-Year Probability of Metastatic Recurrence Following Nephrectomy for Renal Masses (2007) (0)
1470 PROGRESSION TO MUSCLE INVASION DURING SURVEILLANCE OF UROTHELIAL CARCINOMA IS ASSOCIATED WITH POOR PROGNOSIS (2010) (0)
MP64-01 RETROPERITONEAL LYMPH NODE DISSECTION IS NOT ASSOCIATED WITH SURVIVAL OUTCOMES AMONG PATIENTS UNDERGOING RADICAL NEPHRECTOMY FOR NON-METASTATIC RENAL CELL CARCINOMA: A PROPENSITY-SCORE BASED ANALYSIS (2016) (0)
PD11-01 LONG TERM ONCOLOGIC OUTCOMES OF SURGICALLY TREATED RENAL ONCOCYTOMA (2020) (0)
MP66-12 BIM EXPRESSION IN PERITUMORAL LYMPHOCYTES IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN PATIENTS WITH METASTATIC CLEAR CELL RENAL CELL CARCINOMA (2018) (0)
The impact of rhabdoid differentiation on prognosis in patients with grade 4 renal cell carcinoma. (2015) (0)
PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN) IS A MARKER OF SIGNIFICANT PROSTATE CANCER (1999) (0)
Approach to the Management of Large and Advanced Renal Tumors (2018) (0)
PD16-03 THE IMPACT OF PERIOPERATIVE BLOOD TRANSFUSION ON SURVIVAL FOLLOWING NEPHRECTOMY FOR NON METASTATIC RENAL CELL CARCINOMA (2014) (0)
PD59-08 INTERNATIONAL MULTI-INSTITUTIONAL CHARACTERIZATION OF THE PERIOPERATIVE MORBIDITY OF METASTASECTOMY FOR RENAL CELL CARCINOMA (2022) (0)
Clinicopathologic characterization and outcomes for patients with renal medullary carcinoma: Results from the National Cancer Database. (2017) (0)
1683 DO PATIENTS WITH NORMAL RENAL FUNCTION TOLERATE LONGER PERIODS OF WARM ISCHEMIA DURING PARTIAL NEPHRECTOMY COMPARED WITH PATIENTS HARBORING CHRONIC KIDNEY DISEASE (2012) (0)
MANAGEMENT OF CONTRALATERAL RECURRENCE AFTER RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA: PD73‐11 (2017) (0)
1249 PATHOLOGIC ANALYSIS AND ONCOLOGIC OUTCOMES OF RENAL MASSES IN HORSESHOE KIDNEYS (2010) (0)
MP48-14 RADICAL VERSUS PARTIAL NEPHRECTOMY FOR CT1 RENAL CELL CARCINOMA: A PROPENSITY-SCORE BASED ANALYSIS (2018) (0)
Development of a novel immunotherapy for muscle invasive bladder cancer (MIBC). (2017) (0)
PD29-06 ONCOLOGIC SURVEILLANCE FOLLOWING SURGICAL RESECTION FOR RENAL CELL CARCINOMA: A NOVEL RISK-BASED APPROACH (2015) (0)
1803 PROGNOSIS IN PATIENTS WITH MULTIPLE METASTATIC LESIONS OF RENAL CELL CARCINOMA (2010) (0)
PD12-08 THE ASSOCIATION OF LYMPH NODE DISSECTION WITH SURVIVAL IN HIGH-RISK NON-METASTATIC RENAL CELL CARCINOMA: AN ANALYSIS OF THE NATIONAL CANCER DATABASE (2018) (0)
PD49-12 PARTIAL VERSUS RADICAL NEPHRECTOMY IN CLINICAL T2 RENAL MASSES (2020) (0)
BLADDE RCANCE RRIS KFOLLOWIN GPRIMAR YAN DADJUVANT EXTERNA LBEA MRADIATIO NFO RPROSTAT ECANCER (2005) (0)
SURVIVAL FOR RESECTED VERSUS UNRESECTED METASTATIC RENAL CELL CARCINOMA TO THE PANCREAS (2008) (0)
COINHIBITORY MOLECULE EXPRESSION AND LYMPHOCYTIC INFILTRATION IN NON-CLEAR CELL RENAL CELL CARCINOMA (2008) (0)
MP50-10 INCIDENCE AND RISK FACTORS FOR PERIOPERATIVE THROMBOEMBOLIC EVENTS AMONG PATIENTS WITH RENAL CELL CARCINOMA AND INFERIOR VENA CAVA TUMOR THROMBUS (2015) (0)
PD51-03 PERCUTANEOUS ABLATION OFFERS COMPARABLE ONCOLOGIC CONTROL COMPARED WITH PARTIAL NEPHRECTOMY FOR cT1 RENAL MASSES (2019) (0)
PD49-12 CLINICOPATHOLOGIC CHARACTERISTICS AND SURVIVAL FOR ADULT RENAL SARCOMA: A POPULATION-BASED STUDY (2015) (0)
MP42-14 UPSTAGING OF CHRONIC KIDNEY DISEASE AFTER PARTIAL AND RADICAL NEPHRECTOMY (2021) (0)
448: Tumor Vasculature Expression of B7-H3 in Renal Cell Carcinoma (2007) (0)
MP70-11 RADIOGRAPHIC PREDICTORS OF THE NEED FOR INFERIOR VENA CAVAL RESECTION DURING NEPHRECTOMY FOR PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS (2015) (0)
PARTIAL NEPHRECTOMY IN THE TREATMENT OF RENAL TUMORS WITH CONCOMITANT VENOUS TUMOR THROMBOSIS (VTT) OF RENAL VEIN BRANCHES: RETROSPECTIVE, MULTI‐CENTER ANALYSIS OF PERIOPERATIVE, FUNCTIONAL, AND ONCOLOGIC OUTCOMES: MP55‐05 (2017) (0)
MP64-11 EVALUATION OF SURGICAL COMPLICATIONS IN A CONTEMPORARY SERIES OF PARTIAL NEPHRECTOMY PATIENTS (2016) (0)
Molecular and Immunophenotypic Correlates of Metastatic Epithelioid Angiomyolipoma Include Alterations of TP53, RB1, and ATRX. (2022) (0)
MP13-07 NEXT-GENERATION LIQUID BIOPSIES USING EXTRACELLULAR VESICLE DETECTION BY NANOSCALE FLOW CYTOMETRY (2019) (0)
MP35-18 SARCOPENIA IS INDEPENDENTLY ASSOCIATED WITH INCREASED MORTALITY FOLLOWING RADICAL NEPHRECTOMY FOR LOCALIZED RENAL CELL CARCINOMA (2015) (0)
MP-04.07: CD-4+ CD-25+ regulatory T-cells in the tumor draining lymph nodes of patients with urothelial carcinoma (2007) (0)
P125 Excellent long-term disease control with modern radiotherapy techniques for stage I testicular seminoma – the Mayo Clinic experience (2012) (0)
Mass Spectrometry-Based Assessment of Prostate Cancer-Associated Crystalloids Reveals Enrichment for Growth & Differentiation Factor 15 (GDF15). (2023) (0)
87: Dynamic Outcome Prediction in Patients with Clear Cell Renal Cell Carcinoma Treated with Radical Nephrectomy (2006) (0)
MP69-05 EVALUATION OF POST-OPERATIVE COMPLICATIONS AND PROLONGED LENGTH OF STAY FOLLOWING CYTOREDUCTIVE NEPHRECTOMY (2015) (0)
RADICAL NEPHRECTOMY WITH OR WITHOUT LYMPH NODE DISSECTION FOR NON‐METASTATIC RENAL CELL CARCINOMA: A MULTI‐INSTITUTIONAL ANALYSIS: MP55‐16 (2017) (0)
387: The Immunomodulatory Protein B7-H4 Expression in Renal Cell Carcinoma Patients: A Strong Predictor of Cancer Progression and Survival (2006) (0)
PD10-11 AUA AND NCCN SURVEILLANCE GUIDELINES FOR RCC: DO THEY EFFECTIVELY CAPTURE RECURRENCES FOLLOWING NEPHRECTOMY? (2014) (0)
MP73-11 A COMPREHENSIVE COMPETING RISK CALCULATOR FOR PATIENTS WITH CORTICAL RENAL MASSES < 10CM: A NOVEL CLINICAL DECISION AID FOR SHARED DECISION-MAKING REGARDING INDIVIDUALIZED TREATMENT SELECTION (2016) (0)
268: Trends in Gleason Grading of Radical Retropubic Prostatectomy Specimens over Time (2005) (0)
MP6-06 POPULATION-LEVEL TRENDS IN THE ADOPTION OF NOVEL TARGETED AGENTS FOR SYSTEMIC THERAPY AND IMPACT ON RATES OF CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA (2014) (0)
COMBINED EXPRESSION OF B7-H1 AND PD-1 AMONG PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA (2009) (0)
MP63-20 DEVELOPMENT AND EXTERNAL VALIDATION OF A PATHOLOGICAL NODAL STAGING SCORE FOR PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA (2015) (0)
MP64-08 CONTEMPORARY UTILIZATION OF THE SSIGN SCORE (2016) (0)
Bim Expression in Peritumoral Lymphocytes is Associated with Survival in Patients with Metastatic Clear Cell Renal Cell Carcinoma (2021) (0)
Abstract P190: Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients with urothelial carcinoma (2021) (0)
MP50-01 PERCUTANEOUS BIOPSY FOR UPPER TRACT UROTHELIAL CARCINOMA - SAFETY AND DIAGNOSTIC ACCURACY (2019) (0)
MP31-13 DISPARITIES IN RACE AND ETHNICITY REPORTING IN CONTEMPORARY CLINICAL TRIALS LEADING TO NEW DRUG APPROVALS IN UROLOGY (2022) (0)
8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness (2020) (0)
Temporal trends and factors associated with receipt of systemic therapy among patients undergoing cytoreductive nephrectomy. (2014) (0)
NEW PROPOSAL FOR SUBCLASSIFICATION OF STAGE T2 BLADDER CANCER (1999) (0)
319: Survivin and B7-H1 are Collaborative Predictors of Survival and Represent Potential Therapeutic Targets for Patients with Renal cell Carcinoma (2007) (0)
Predictors and outcomes for late recurrence of renal cell carcinoma. (2011) (0)
Immune cell marker expressed in kidney cancer and predicts aggressiveness (2004) (0)
Reply by the Authors. (2018) (0)
537 NEPHROMETRY SCORE INTEROBSERVER AGREEMENT IS ROBUST ACROSS SPECIALTIES AND LEVELS OF TRAINING (2011) (0)
What is the clinical significance of ipsilateral renal lesions during nephron-sparing surgery? (2008) (0)
International Multi-institutional Characterization of the Perioperative Morbidity of Metastasectomy for Renal Cell Carcinoma. (2022) (0)
A MOLECULAR SCORING ALGORITHM TO PREDICT SURVIVAL IN METASTATIC RENAL CELL CARCINOMA: PD52‐11 (2017) (0)
827 FACTORS ASSOCIATED WITH MANAGEMENT OF SMALL RENAL MASSES: A SURVEY OF THE AMERICAL UROLOGICAL ASSOCIATION (2010) (0)
Bilateral Renal Masses (2008) (0)
MP57-10 RISK FACTORS FOR MAJOR COMPLICATIONS AND PERIOPERATIVE MORTALITY FOLLOWING SURGICAL RESECTION OF RENAL CELL CARCINOMA WITH UPPER LEVEL IVC THROMBUS: A CONTEMPORARY MULTI-CENTER EXPERIENCE (2014) (0)
Adult urologyOncology: Adrenal/renal/upper tract/bladderEditorial Comment (2006) (0)
The probability of indolent versus aggressive histology based on renal tumor size: Implications for surveillance and treatment. (2018) (0)
1088 PREDICTORS AND OUTCOMES OF LATE RECURRENCE FROM RENAL CELL CARCINOMA FOLLOWING SURGICAL RESECTION (2011) (0)
1904 THE IMPACT OF NON-CLEAR CELL HISTOLOGY ON OUTCOME FOR PATIENT WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS (2013) (0)
A validation/evaluation of five postoperative prognostic tools for prostate cancer (2007) (0)
730 ASSOCIATION OF MICROVASCULAR AND CAPILLARY-LYMPHATIC INVASION WITH OUTCOME FOR PATIENTS WITH RENAL CELL CARCINOMA FOLLOWING NEPHRECTOMY (2013) (0)
MP33-08 DEEP LEARNING RENAL VOLUME ANALYSIS TO PREDICT LONG-TERM RENAL FUNCTION AFTER PARTIAL AND RADICAL NEPHRECTOMY (2022) (0)
MP70-12 IS CONCOMITANT HEPATIC RESECTION FOR LOCALLY ADVANCED OR METASTATIC RENAL CELL CARCINOMA AT THE TIME OF NEPHRECTOMY SAFE? A MATCHED COHORT STUDY (2015) (0)
1587: Primary Gleason Grade 4 Prostate Cancer Treated by Radical Prostatectomy: Pathological Stage, DNA Ploidy and Tumor Size are Stronger Determinants of Survival than Secondary Gleason Grade (2006) (0)
PD17-09 CD70-POSITIVE EXTRACELLULAR VESICLES FOR DETECTION OF CLEAR-CELL RENAL CELL CARCINOMA (2023) (0)
Creation of a tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma. (2018) (0)
224: Post-Operative Prostate Cancer Surveillance: Detecting Recurrence While Maintaining Cost-Effective Care (2006) (0)
Abstract 15: Association of topoisomerase II expression and cancer-specific death in patients with surgically-resected clear cell renal cell carcinoma. (2013) (0)
646: 25-Year Outcomes of Radical Prostatectomy for the Treatment of All Stages of Non-Metastatic Prostate Cancer (2006) (0)
CREATION OF A PREDICTION TOOL FOR RENAL FUNCTION AFTER PARTIAL AND RADICAL NEPHRECTOMY: PERSONALIZING DECISION‐MAKING FOR RENAL CANCER SURGERY: PD66‐07 (2017) (0)
959: Subtype-Specific Multifactorial Postoperative Suriveillance Protocol for Patients with Surgically Treated Renal Cell Carcinoma (2005) (0)
1603: Parkinson's Disease Impact on Voiding Function After Radical Prostatectomy (2006) (0)
PD17-10 DISCOVERY OF A NOVEL MONOCLONAL PD-L1 ANTIBODY H1A THAT PROMOTES T-CELL MEDIATED TUMOR KILLING ACTIVITY IN RENAL CELL CARCINOMA (2023) (0)
MP21-03 CD-70 BLOCKADE AS A NOVEL IMMUNOTHERAPY FOR THE TREATMENT OF CLEAR-CELL RENAL CELL CARCINOMA (2019) (0)
Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencing (2019) (0)
AUA and NCCN surveillance guidelines for RCC: Do they effectively capture recurrences following nephrectomy? (2014) (0)
PREDICTING RENAL CELL CARCINOMA PROGRESSION AFTER SURGERY: MP72‐01 (2017) (0)
PD57-07 RAPID PATIENT DERIVED XENOGRAFTS THAT CONSIDER TUMOR HETEROGENEITY FOR PREDICTION OF CANCER IMMUNOTHERAPY RESPONSES IN METASTATIC RENAL CELL CARCINOMA (2018) (0)
MP58-09 TRUE LOCAL RECURRENCE FOLLOWING PARTIAL NEPHRECTOMY (2023) (0)
PATHOLOGIC PREDICTORS OF MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER FOLLOWING RADICAL NEPHROURETERECTOMY: PD73‐12 (2017) (0)
Mp70-14 The Oncologic Impact Of Positive Vascular Wall Surgical Margins In Patients With Renal Cell Carcinoma And Venous Tumor Thrombus Undergoing Nephrectomy (2015) (0)
73: Preoperative and Intraoperative Features Associated with Positive Lymph Nodes During Nephrectomy for Renal Cell Carcinoma (2006) (0)
RENAL MASS SIZE AND SYNCHRONOUS METASTATIC DISEASE IN RENAL CELL CARCINOMA: AN ANALYSIS OF THE NATIONAL CANCER DATABASE: MP22‐15 (2017) (0)
SURGICAL MANAGEMENT OF UROTHELIAL CARCINOMA IN PATIENTS WITH UPPER TRACT AND LOWER TRACT UROTHELIAL CARCINOMA: IMPACT OF SURGICAL SEQUENCE: MP78‐19 (2017) (0)
PD57-02 CREATION OF A TISSUE EXPRESSION BIOMARKER-AUGMENTED PROGNOSTIC MODEL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (2018) (0)
UTILIZATION OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA IN A CONTEMPORARY TERTIARY CARE COHORT: MP10‐16 (2017) (0)
PD04-04 OPTIMIZING PATIENT SELECTION FOR CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA (2016) (0)
1121: The Relationship between Renal Angiomyolipoma, Renal Cell Carcinoma and Tuberous Sclerosis (2006) (0)
960: Preoperative Prediction of Pathologic Features and Outcome in Patients with Clinically Confined Solid Renal Tumors (2005) (0)
728: Dynamic Assessment of Systemic Progression Risk after Radical Retropubic Prostatectomy (2007) (0)
Diabetes mellitus and risk of cancer-specific mortality among patients with clear cell renal cell carcinoma undergoing nephrectomy. (2014) (0)
LONG-TERM OUTCOME OF MULTIPLE IPSILATERAL RENAL TUMORS FOUND AT TIME OF PLANNED NEPHRON SPARING SURGERY (2008) (0)
733: Cancer-Specific Mortality is Increased by Erythrocyte Transfusion in Patients Undergoing Surgery for Renal Cell Carcinoma (2006) (0)
PD24-07 THE NATURAL HISTORY OF RENAL CELL CARCINOMA WITH ISOLATED LYMPH NODE METASTASES IN THE TARGETED THERAPY ERA (2018) (0)
507: Patients with PT1 Renal Cell Carcinoma who Die from Disease after Nephrectomy may have Unrecognized Renal Sinus Fat Invasion (2007) (0)
271: Age at Treatment is not a Good Predictor of Outcome Following Radical Retropubic Prostatectomy (2005) (0)
p53 STATUS PREDICTS RECURRENCE AND PROGRESSION OF LOW STAGE (<or= to T1) UROTHELIAL CARCINOMA OF THE BLADDER (1999) (0)
MP03-05 RADIOGRAPHIC SIZE OF RETROPERITONEAL LYMPH NODES PREDICTS PATHOLOGIC NODAL INVOLVEMENT FOR PATIENTS UNDERGOING RADICAL NEPHRECTOMY FOR RENAL CELL CARCINOMA: DEVELOPMENT OF A RISK PREDICTION MODEL (2016) (0)
Prognostic impact of peripheral blood counts in patients with non-metastatic clear cell renal cell carcinoma. (2015) (0)
PD16-12 PROGNOSTIC EVALUATION OF PERINEPHRIC FAT, RENAL SINUS FAT, AND RENAL VEIN INVASION FOR PATIENTS WITH PATHOLOGIC STAGE T3A RENAL CELL CARCINOMA (2018) (0)
Likelihood of high volume renal surgeons to offer elective partial nephrectomy in high complexity tumors as classified by the nephrometry scoring system. (2011) (0)
1098: Potential Underdetection of PT3A Renal Cell Carcinoma with Laparoscopic Morcellation (2006) (0)
Hereditary syndromes of kidney cancer : chromosomal localisation , affected genes and pathways , and clinical features Syndrome Chromosome Gene / protein Potential pathway (2012) (0)
Perioperative morbidity of surgical metastasectomy for renal cell carcinoma: An international multicenter study (2022) (0)
OPTIMAL OUTCOME PREDICTION AFTER RADICAL PROSTATECTOMY (1999) (0)
PD56-03 CONTEMPORARY PERIOPERATIVE COMPLICATIONS OF SURGERY FOR RENAL CELL CARCINOMA WITH INFERIOR VENA CAVA THROMBECTOMY (2022) (0)
45: Effect of Vascular Clamping on Postoperative Renal Function and Complication Rates in Patients Undergoing Open Nephron-Sparing Surgery on a Solitary Kidney: A Multi-Institutional Study (2005) (0)
MP59-04 PREOPERATIVE NEUTROPHIL LYMPHOCYTE RATIO IS AN INDEPENDENT PREDICTOR OF CANCER SPECIFIC SURVIVAL IN PATIENTS WITH NONMETASTATIC CLEAR CELL RENAL CARCINOMA UNDERGOING RADICAL NEPHRECTOMY (2014) (0)
Cytogenetics of Spermatocytic Tumors with a Discussion of Gain of Chromosome 12p in "Anaplastic Variants". (2022) (0)
still believe that the absence of staining in oncocytoma and chromo- phobe RCC (reiterated in their Table) may prove useful for patholo- gists reviewing needle biopsy specimens of renal masses. (2008) (0)
IMPACT OF FAMILY HISTORY ON OUTCOME IN RENAL CELL CARCINOMA (2008) (0)
PD33-03 IS ANGIOTENSIN SYSTEM INHIBITOR USE ASSOCIATED WITH IMPROVED OUTCOMES IN PATIENTS WITH LOCALIZED CLEAR CELL RCC? (2022) (0)
Gross and Laparoscopic Anatomy of the Upper Tract and Retroperitoneum (2020) (0)
OUTCOMES ON ILEAL MUCOSAL CUFF MANAGEMENT DURING RADICAL NEPHROURETERECTOMY: PD66‐12 (2017) (0)
MP15-05 PROSPECTIVE EVALUATION OF OPIOID UTILIZATION AFTER MINIMALLY INVASIVE PROSTATE AND RENAL SURGERY – AN ANALYSIS OF PATIENT FACTORS (2019) (0)
143: Is the GPSM Scoring Algorithm for Prostate Cancer Patients Valid in the Contemporary ERA? (2006) (0)
965: Erythrocyte Sedimentation Rate: An Independent Prognostic Feature of Clear Cell Renal Cell Cancer (2005) (0)
Health Care Transformations Merging Traditional and Digital Medical Practices (2023) (0)
88: How Long is Too Long? Examining the Effect of Duration of Anesthesia on the Incidence of Non-Urologic Complications in the Urologic Patient (2005) (0)
1907: The Role of Inferior Vena Caval Interruption During Radical Nephrectomy and Tumor Thrombectomy (2007) (0)
MP42-13 ASSOCIATION OF PARTIAL VERSUS RADICAL NEPHRECTOMY WITH SUBSEQUENT HYPERTENSION RISK FOLLOWING RENAL TUMOR RESECTION (2019) (0)
Nephron-sparing surgery and renal cell carcinoma. Authors' reply (2004) (0)
MP54-12 DIABETES MELLITUS IS ASSOCIATED WITH AN INCREASED RISK OF CANCER-SPECIFIC MORTALITY AMONG PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA UNDERGOING NEPHRECTOMY (2014) (0)
482: The Long-Term Impact of Obesity on Prostate Cancer After Radical Prostatectomy (2006) (0)
MP03-11 RETROPERITONEAL LYMPH NODE DISSECTION IS NOT ASSOCIATED WITH IMPROVED SURVIVAL AMONG PATIENTS UNDERGOING CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: A PROPENSITY-SCORE BASED ANALYSIS (2016) (0)
Clinical/ Immunopathological Presentations and Antigen-specific CD8+ T Cell Responses in Paraneoplastic Autoimmune KLHL11 Encephalitis (1185) (2020) (0)
Long-term Outcomes of the Combined Approach of Maximal Surgical Resection and Intraoperative Electron Radiotherapy for Recurrent or Locally Advanced Renal Malignancies (2010) (0)
Oncology: Adrenal/Renal/Upper Tract/Bladder Association of Microvascular and Capillary-Lymphatic Invasion with Outcome in Patients with Renal Cell Carcinoma (2013) (0)
MP58-02 EVALUATION OF AMERICAN UROLOGICAL ASSOCIATION RENAL CELL CARCINOMA RISK GROUPS FOR CHROMOPHOBE RENAL CELL CARCINOMA (2023) (0)
MP42-12 END-STAGE KIDNEY DISEASE AFTER PARTIAL AND RADICAL NEPHRECTOMY AMONG PATIENTS WITH SEVERE CHRONIC KIDNEY DISEASE (2021) (0)
383: Rare Expression or Mutation of C-KIT in Grade 4 Renal Cell Carcinoma with or without Sarcomatoid Differentiation (2006) (0)
Progression of Chronic Kidney Disease Following Radical and Partial Nephrectomy. (2022) (0)
MP33-03 COMPARATIVE COST-EFFECTIVENESS OF TREATMENT STRATEGIES FOR STAGE IIA SEMINOMA: INSIGHTS FROM THE SEMS TRIAL (2023) (0)
The [overlooked] cancer. Mayo Clinic's Bradley Leibovich, M.D., on recent progress in treating kidney cancer [interview by Peota Carmen]. (2010) (0)
386: Tumor B7-H1 is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long Term Follow-Up (2006) (0)
CD-4+ CD-25hi REGULATORY T-CELLS IN THE REGIONAL LYMPH NODES OF PATIENTS WITH UROTHELIAL CARCINOMA (2008) (0)
Coffee consumption and risk of renal cell carcinoma (2017) (0)
LBA-15 RENAL HYPOTHERMIA DURING PARTIAL NEPHRECTOMY: A RANDOMIZED CONTROLLED TRIAL (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Bradley C. Leibovich?

Bradley C. Leibovich is affiliated with the following schools:

University of Kentucky
Mayo Clinic College of Medicine and Science
Duke University
University of Cambridge